Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

● In a short-term perspective, the company has interesting fundamentals.


Strengths

● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 49% by 2022.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.67 for the 2020 fiscal year.

● This company will be of major interest to investors in search of a high dividend stock.

● Analysts covering this company mostly recommend stock overweighting or purchase.


Weaknesses

● The company sustains low margins.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● For the past year, analysts have significantly revised downwards their profit estimates.